Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta
Clinical trial NCT05950802 · RECRUITING
Trial details
- NCT number
- NCT05950802
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2027-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.